Announcement PDF Appendix 3B - Proposed issue of securities Announcement Summary Entity name PARADIGM BIOPHARMACEUTICALS LIMITED.. Announcement Type New announcement Date of this announcement 3/2/2025 The Proposed issue is: A bonus issue Total number of +securities proposed to be issued for a bonus issue ASX +security code +Security description New class-code to be confirmed Loyalty Option Maximum Number of +securities to be issued 97,357,151 Ex date 6/2/2025 +Record date 7/2/2025 +Issue date 11/2/2025 Refer to next page for full details of the announcement Appendix 3B - Proposed issue of securities 1/5 Appendix 3B - Proposed issue of securities Part 1 - Entity and announcement details 1.1 Name of +Entity PARADIGM BIOPHARMACEUTICALS LIMITED.. We (the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees to +quote any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in Appendix 3B of the ASX Listing Rules. If the +securities are being offered under a +disclosure document or +PDS and are intended to be quoted on ASX, we also apply for quotation of all of the +securities that may be issued under the +disclosure document or +PDS on the terms set out in Appendix 2A of the ASX Listing Rules (on the understanding that once the final number of +securities issued under the +disclosure document or +PDS is known, in accordance with Listing Rule 3.10.3C, we will complete and lodge with ASX an Appendix 2A online form notifying ASX of their issue and applying for their quotation). 1.2 Registered Number Type Registration Number ACN 169346963 1.3 ASX issuer code PAR 1.4 The announcement is New announcement 1.5 Date of this announcement 3/2/2025 1.6 The Proposed issue is: A +bonus issue Appendix 3B - Proposed issue of securities 2/5 Appendix 3B - Proposed issue of securities Part 2 - Details of proposed bonus issue Part 2A - Conditions 2A.1 Do any external approvals need to be obtained or other conditions satisfied before the +bonus issue can proceed on an unconditional basis? No Part 2B - Issue details +Class or classes of +securities that will participate in the proposed issue and +class or classes of +securities proposed to be issued ASX +security code and description PAR : ORDINARY FULLY PAID Is the proposed security a 'New class' (+securities in a class that is not yet quoted or recorded by ASX) or an 'Existing class' (additional securities in a class that is already quoted or recorded by ASX)? New class Will the proposed issue of this +security include an offer of attaching +securities? No If the entity has quoted company options, do the terms entitle option holders to participate on exercise? No Details of +securities proposed to be issued ISIN Code (if Issuer is a foreign company and +securities do not have +CDIs issued over them) Have you received confirmation from ASX that the terms of the proposed +securities are appropriate and equitable under listing rule 6.1? No Will the entity be seeking quotation of the 'new' class of +securities on ASX? Yes ASX +security code +Security description New class-code to be confirmed Loyalty Option +Security type Options Issue ratio (ratio to existing holdings at which the proposed +securities will be issued) The quantity of additional +securities For a given quantity of +securities to be issued held 1 What will be done with fractional Appendix 3B - Proposed issue of securities 4 Maximum number of +securities proposed to be issued (subject to 3/5 Appendix 3B - Proposed issue of securities What will be done with fractional entitlements? proposed to be issued (subject to rounding) 97,357,151 Fractions rounded up to the next whole number Will all the +securities issued in this class rank equally in all respects from their issue date? Yes Options details +Security currency Exercise price Expiry date AUD - Australian Dollar AUD 0.6500 11/2/2026 Details of the type of +security that will be issued if the option is exercised PAR : ORDINARY FULLY PAID Number of securities that will be issued if the option is exercised 97,357,151 ORDINARY SHARES Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities proposed to be issued or provide the information by separate announcement. https://announcements.asx.com.au/asxpdf/20250131/pdf/06f1sv4mt33jls.pdf Part 2C - Timetable 2C.1 +Record date 7/2/2025 2C.3 Ex date 6/2/2025 2C.4 Record date 7/2/2025 2C.5 +Issue date 11/2/2025 2C.6 Date trading starts on a normal T+2 basis 12/2/2025 2C.7 First settlement of trades conducted on a +deferred settlement basis and on a normal T+2 basis 14/2/2025 Appendix 3B - Proposed issue of securities 4/5 Appendix 3B - Proposed issue of securities Part 2D - Further Information 2D.1 Will holdings on different registers or subregisters be aggregated for the purposes of determining entitlements to the +bonus issue? No 2D.2 Countries in which the entity has +security holders who will not be eligible to participate in the proposed +bonus issue Shareholders with a registered address which is outside Australia, New Zealand, Singapore, United Kingdom and Hong Kong (Permitted Jurisdictions) 2D.3 Will the entity be changing its dividend/distribution policy as a result of the proposed +bonus issue No 2D.4 Details of any material fees or costs to be incurred by the entity in connection with the proposed +bonus issue 2D.5 Any other information the entity wishes to provide about the proposed +bonus issue A further offer to eligible Loyalty Option holders of one (1) Option (Piggyback Option) for every two (2) Loyalty Options exercised on or before the expiry of the Loyalty Option, exercisable at $1.00 each on or before the date that is 24 months from the expiry of the Loyalty Option, which will be issued on each exercise of Loyalty Options Appendix 3B - Proposed issue of securities 5/5